Effect of CYP2C9, VKORC1, CYP4F2 and GGCX genetic variants on warfarin maintenance dose and explicating a new pharmacogenetic algorithm in South Indian population

被引：0
|
作者：
Dhakchinamoorthi Krishna Kumar
Deepak Gopal Shewade
Marie-Anne Loriot
Philippe Beaune
Jayaraman Balachander
B. V. Sai Chandran
Chandrasekaran Adithan
机构：
[1] Jawaharlal Institute of Postgraduate Medical Education & Research (JIPMER),Department of Pharmacology
[2] INSERM UMRS 775,University Paris Sorbonne Cité
[3] Assistance Publique des Hôpitaux de Paris,Department of Biochemistry, Georges Pompidou European Hospital
[4] Jawaharlal Institute of Postgraduate Medical Education & Research (JIPMER),Department of Cardiology
[5] Jawaharlal Institute of Postgraduate Medical Education & Research (JIPMER),Department of Cardiothoracic and Vascular Surgery
来源：
European Journal of Clinical Pharmacology | 2014年 / 70卷
关键词：
Warfarin; Genotype; Polymorphisms; Pharmacogenetic algorithm;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：47 / 56
页数：9
相关论文
共 50 条
  • [1] Effect of CYP2C9, VKORC1, CYP4F2 and GGCX genetic variants on warfarin maintenance dose and explicating a new pharmacogenetic algorithm in South Indian population
    Kumar, Dhakchinamoorthi Krishna
    Shewade, Deepak Gopal
    Loriot, Marie-Anne
    Beaune, Philippe
    Balachander, Jayaraman
    Chandran, B. V. Sai
    Adithan, Chandrasekaran
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2014, 70 (01) : 47 - 56
  • [2] Genetic epidemiology of pharmacogenetic variations in CYP2C9, CYP4F2 and VKORC1 genes associated with warfarin dosage in the Indian population
    Giri, Anil K.
    Khan, Nazir M.
    Grover, Sandeep
    Kaur, Ismeet
    Basu, Analabha
    Tandon, Nikhil
    Scaria, Vinod
    Kukreti, Ritushree
    Brahmachari, Samir K.
    Bharadwaj, Dwaipayan
    PHARMACOGENOMICS, 2014, 15 (10) : 1337 - 1354
  • [3] Interpretation of the effect of CYP2C9, VKORC1 and CYP4F2 variants on warfarin dosing adjustment in Turkey
    Kocael, Ahmet
    Eronat, Allison Pinar
    Tuzuner, Mete Bora
    Ekmekci, Ahmet
    Orhan, Ahmet Lutfullah
    Ikizceli, Ibrahim
    Yilmaz-Aydogan, Hulya
    Ozturk, Oguz
    MOLECULAR BIOLOGY REPORTS, 2019, 46 (02) : 1825 - 1833
  • [4] Impact of Genetic Factors (CYP2C9, VKORC1 and CYP4F2) on Warfarin Dose Requirement in the Turkish Population
    Ozer, Mahmut
    Demirci, Yeliz
    Hizel, Candan
    Sarikaya, Sabit
    Karalti, Iskender
    Kaspar, Cigdem
    Alpan, Serdar
    Genc, Ece
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2013, 112 (03) : 209 - 214
  • [5] Copy number variation and warfarin dosing: evaluation of CYP2C9, VKORC1, CYP4F2, GGCX and CALU
    Scott, Stuart A.
    Patel, Manishkumar
    Martis, Suparna
    Lubitz, Steven A.
    van der Zee, Sarina
    Yoo, Chang
    Edelmann, Lisa
    Halperin, Jonathan L.
    Desnick, Robert J.
    PHARMACOGENOMICS, 2012, 13 (03) : 297 - 307
  • [6] Responsiveness to low-dose warfarin associated with genetic variants of VKORC1, CYP2C9, CYP2C19, and CYP4F2 in an Indonesian population
    Rusdiana, T.
    Araki, T.
    Nakamura, T.
    Subarnas, A.
    Yamamoto, K.
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2013, 69 (03) : 395 - 405
  • [7] Effect of VKORC1, CYP2C9 and CYP4F2 genetic variants in early outcomes during acenocoumarol treatment
    Jose Cerezo-Manchado, Juan
    Roldan, Vanessa
    Rosafalco, Mario
    Isabel Anton, Ana
    Belen Arroyo, Ana
    Garcia-Barbera, Nuria
    Belen Martinez, Ana
    Padilla, Jose
    Corral, Javier
    Vicente, Vicente
    Gonzalez-Conejero, Rocio
    PHARMACOGENOMICS, 2014, 15 (07) : 987 - 996
  • [8] Responsiveness to low-dose warfarin associated with genetic variants of VKORC1, CYP2C9, CYP2C19, and CYP4F2 in an Indonesian population
    T. Rusdiana
    T. Araki
    T. Nakamura
    A. Subarnas
    K. Yamamoto
    European Journal of Clinical Pharmacology, 2013, 69 : 395 - 405
  • [9] VKORC1, CYP2C9 and CYP4F2 genetic-based algorithm for warfarin dosing: an Italian retrospective study
    Zambon, Carlo-Federico
    Pengo, Vittorio
    Padrini, Roberto
    Basso, Daniela
    Schiavon, Stefania
    Fogar, Paola
    Nisi, Alessandra
    Frigo, Anna Chiara
    Moz, Stefania
    Pelloso, Michela
    Plebani, Mario
    PHARMACOGENOMICS, 2011, 12 (01) : 15 - 25
  • [10] Effect of CYP2C9, CYP4F2 and VKORC1 genetic polymorphisms on pharmacokinetics and pharmacodynamics of mean daily maintenance dose of warfarin in Chinese patients
    Zhuang, Wenfang
    Wen, Wei
    Xuan, Binbin
    Chen, Yanhong
    Cao, Yanan
    Sun, Zhixin
    Ma, Jun
    BLOOD COAGULATION & FIBRINOLYSIS, 2015, 26 (02) : 167 - 174
12345